Schwannoma of ascending colon treated by laparoscopic right hemicolectomy
- 3.1k Downloads
Schwannomas of the colon are rare and are difficult to diagnose preoperatively, since they often defy endoscopic and radiographic detection. Immunohistochemical stains are useful postoperatively to confirm this tumor, but more reliable diagnostic techniques (such as colonoscopic biopsy with immunohistochemistry) have emerged to enhance preoperative diagnostic accuracy. Here we report an instance of schwannoma arising in the ascending colon, where immunohistochemical staining of a preoperative biopsy facilitated diagnosis. After laparoscopic resection, histologic examination was confirmatory.
KeywordsSchwannoma Ascending colon Immunohistochemistry
Schwannomas of the gastrointestinal tract are relatively uncommon and rarely involve the large intestine [1, 2, 3]. Although considered benign, they may recur locally (if incompletely excised), and malignant transformation is occasionally observed [4, 5]. Radical surgery is, therefore, the accepted standard of treatment.
While accurate diagnosis prior to surgical intervention can aid in therapeutic planning, limitations of conventional imaging and lack of sufficient biopsy material usually make this difficult. Recent improvements in colonoscopic techniques have led to use of endoscopic biopsy and immunohistochemistry in combination as a more reliable method for accurate preoperative assessment. We report here an instance of schwannoma of the ascending colon, confirmed by immunohistochemistry, for which laparoscopic right hemicolectomy was performed.
Schwannomas are uncommon neoplasms arising from Schwann cells of the neural sheath [2, 6]. They may occur anywhere in the body, but gastrointestinal sites are rare, especially the colon [1, 2, 3, 7, 8, 9, 10, 11, 12]. Depending on tumor size and location, schwannomas of the colon may occasionally produce symptoms, such as constipation, bleeding, abdominal pain or discomfort, and anal pain [2, 10]. Intussuception is unusual . Most patients, however, have no symptoms, because these are inherently slow-growing neoplasms [9, 13]. In our patient, tumor discovery was incidental.
Preoperative diagnosis of schwannoma is difficult due to its tissue density and the tendency for ulceration . Biopsies are often nondiagnostic, and information gained by other means is limited. Colonoscopy, abdominal ultrasound (US), abdominal CT and abdominal magnetic resonance imaging (MRI) may aid in evaluating the contours of colorectal schwannomas and their relationship with surrounding organs, as well as tumor multiplicity or metastasis. Levy, et al.  described gastrointestinal schwannomas as homogeneously attenuated and well-defined mural masses on CT, noting that they were indistinguishable from gastrointestinal stromal tumors. Low-attenuation hemorrhage, necrosis and internal degeneration constituted shared CT features. Attributes signifying benign vs malignant behavior were not addressed [15, 16]. More recently, endoscopic ultrasonography (EUS) surpassed other imaging modalities in diagnostic accuracy but still will not differentiate a schwannoma from other gastrointestinal stromal tumors. EUS-guided fine needle aspiration or biopsy of submucosal tumors has been attempted [17, 18, 19, 20].
Schwannoma of the colon usually is not diagnosable solely by routine histology. A newer, more reliable approach incorporates immunohistochemistry [2, 7]. Characteristically, these tumors are composed of spindle cells (much like neurofibromas, gastrointestinal stromal tumors and leiomyomas) [7, 21] that are 100% immunoreactive for S-100 protein. Cells of neurofibroma show less S-100 positivity (30% to 40%), while gastrointestinal stromal tumors are generally positive for CD117(c-kit) and CD34 (70%) and negative for S-100 protein. Leiomyomas similarly are devoid of S-100 protein, expressing smooth muscle actin and desmin instead [22, 23].
Because the prognosis for schwannoma differs from other gastrointestinal stromal tumors, a correct diagnosis is critical. Schwannomas overall are considered benign, but they may recur locally if excision is incomplete and in rare instances are capable of malignant transformation [4, 5]. Tozbikian et al.  found that gastric schwannomas on occasion could be aggressive, progressing rapidly and responding poorly to chemotherapy.
Standard treatment for schwannomas is complete surgical resection [4, 24]. The role of radiotherapy or chemotherapy to date remains unclear [4, 25]. Lymph node resection is not recommended, because the risk of malignant change is low [24, 26]. A minimally invasive procedure (in our case, laparoscopic surgery) is acceptable for schwannoma of the colon and rectum [8, 13, 27]. Our patient resumed oral feeding on the second postoperative day and after an uneventful stay, was discharged on the sixth postoperative day. In clinical follow-up, he has been well and problem-free.
In conclusion, schwannomas of the ascending colon are rare tumors dependent upon immunohistochemistry for definitive classification. Accurate preoperative diagnosis is essential for appropriate surgical management. While radical resection affords optimal outcomes, a laparoscopic approach may be used.
Written informed consent was obtained from the patient for publication of this report and any accompanying images.
- 6.Matsuki A, Kosugi S, Kanda T, Komukai S, Ohashi M, Umezu H, Mashima Y, Suzuki T, Hatakeyama K: Schwannoma of the esophagus: a case exhibiting high 18 F-fluorodeoxyglucose uptake in positron emission tomography imaging. Dis Esophagus. 2009, 22: E6-E10. 10.1111/j.1442-2050.2007.00712.x.CrossRefPubMedGoogle Scholar
- 20.Larghi A, Verna EC, Ricci R, Seerden TC, Galasso D, Carnuccio A, Uchida N, Rindi G, Costamagna G: EUS-guided fine-needle tissue acquisition by using a 19-gauge needle in a selected patient population: a prospective study. Gastrointest Endosc. 2011, 74: 504-510. 10.1016/j.gie.2011.05.014.CrossRefPubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.